Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
27.77
-0.39 (-1.38%)
Official Closing Price
Updated: 6:30 PM EDT, May 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
A Look At Pharma ETFs Post Q1 Earnings
Today 15:11 EDT
Pharma ETFs have delivered mixed performances over the past month.
Via
Talk Markets
Topics
ETFs
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
Today 14:04 EDT
Investors concerned about broader market undulations may want to consider the resilience narrative of these biotech stocks to buy.
Via
InvestorPlace
Tuesday Talk: Still Flying
Today 5:00 EDT
The stock market is still on the upswing. For all the anti-Fed pundits, the market seems to be going with Chairman Powell for now.
Via
Talk Markets
Pfizer's Options Frenzy: What You Need to Know
May 06, 2024
Via
Benzinga
Maximize Your Dividends: 7 Stocks Trading Under $50 with 5%+ Yields
May 06, 2024
Investing in high-yield dividend stocks under $50 is a low-risk strategy that can result in massive returns in time.
Via
InvestorPlace
Pfizer Unusual Options Activity
May 02, 2024
Via
Benzinga
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
May 02, 2024
The pharma-giant's shares could be poised for a trend reversal.
Via
The Motley Fool
What's Going With BioNTech Stock On Monday?
May 06, 2024
BioNTech reports Q1 loss, missing revenue expectations. Despite challenges, BioNTech aims for significant growth, fueled by innovative R&D and strong cash reserves.
Via
Benzinga
How this baseball All-Star steps up to the plate when it comes to pneumococcal pneumonia
May 06, 2024
(BPT) - Professional baseball player JD Martinez is at increased risk for pneumococcal pneumonia because he has asthma, and he doesn't want to let it stop him from taking his shot on - or off - the...
Via
Brandpoint
Revive Your Portfolio: 3 Undervalued Stocks Poised for Growth
May 06, 2024
While big splashes of red ink represent danger, for contrarian investors, these undervalued growth stocks may spell opportunity.
Via
InvestorPlace
3 No-Brainer Stocks to Buy in May
May 05, 2024
These great stocks are great picks for investors as spring winds down.
Via
The Motley Fool
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
May 04, 2024
Where there's a will, there's a way. And Pfizer appears to have the will to stake a claim in the massive obesity drug market.
Via
The Motley Fool
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
May 04, 2024
These highly advantaged businesses have what they need to keep raising their dividend payouts.
Via
The Motley Fool
Stock Market Rallies On Fed, Jobs Report, Apple: Weekly Review
May 03, 2024
The Nasdaq regained its 50-day line Friday. The other indexes hit resistance.
Via
Investor's Business Daily
Topics
Economy
Exposures
Interest Rates
3 Ultra-Safe Stocks to Buy So You Can Rest Easy in Any Market
May 03, 2024
Defensive stocks are increasingly safe to buy and attractive as volatility rises and indices fall at large, making time tested shares hot.
Via
InvestorPlace
Pfizer Prospects Garner Mixed Sentiment From Analysts: 'Finally, The Pivot Investors Have Been Waiting For'
May 02, 2024
Pfizer analysts from Goldman see a positive outlook on Padcev, Prevnar, and Vindaqel, but Nurtec and Oxbryta execution needs work.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
May 02, 2024
Via
Benzinga
3 Contrarian Stocks That Could Make You a Fortune (If You Dare)
May 02, 2024
Sometimes the best way to invest your money is in the companies no one is bullish about, just like these three contrarian stocks to buy.
Via
InvestorPlace
Moderna Puts Up Big Quarterly Beat; Could Shares Notch A Breakout?
May 02, 2024
Moderna is forming its first base in over a year. Could shares top a buy point on the company's sales beat?
Via
Investor's Business Daily
My Top 5 Favorite High-Yield Dividend Stocks to Buy in May
May 02, 2024
Income investors can buy in May and go away with these stocks.
Via
The Motley Fool
Thoughts For Thursday: Lingering Inflation
May 02, 2024
The Fed had expected to lower interest rates by now, but according to Chairman Powell, inflation is sticking around longer than expected and therefore higher rates will stick around longer, too.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Investor Optimism Improves Slightly Following Fed Decision
May 02, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Carvana, Enovix, Pfizer, Nio, Tesla: Why These 5 Stocks Are On Investors' Radars Today
May 01, 2024
Wednesday saw a mixed performance in major U.S. indices. The Dow Jones Industrial Average closed the day with a 0.2% increase at 37,903.29.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Pfizer (PFE) Q1 2024 Earnings Call Transcript
May 01, 2024
PFE earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Pfizer Stock Blasted More Than 6% Higher Today
May 01, 2024
A double beat on earnings, plus raised bottom-line guidance, made the company a hot item on Hump Day.
Via
The Motley Fool
Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates
May 01, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
US Stocks Mixed Ahead Of Fed Meeting, Chipmakers Tumble After AMD Earnings, Bitcoin Sinks: What's Driving Markets Wednesday?
May 01, 2024
Traders are treading cautiously in Wednesday’s session, seeking more clarity on the Federal Reserve’s stance with inflation reports exceeding expectations.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
PFE Stock Earnings: Pfizer Beats EPS, Beats Revenue for Q1 2024
May 01, 2024
PFE stock results show that Pfizer beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Pfizer Q1 Earnings and Revenues Beat Estimates
May 01, 2024
PFE came out with quarterly earnings of $0.82 per share, beating the our eimate of $0.56 per share. This compares to earnings of $1.23 per share a year ago.
Via
Talk Markets
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With Expectations
May 01, 2024
Pfizer reports Q1 results: adjusted EPS beats estimates, driven by revenue growth. Significant declines in Comirnaty and Paxlovid revenues countered by operational gains. Company announces plans for...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.